Stocktoria
Clearside Biomedical, Inc. CLSDQ
OTC · stock · Pharmaceutical Preparations · website · IPO 2016-06-02
Clearside Biomedical, Inc. statistics & valuation
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -1735.7% | -302.0% | -2281.6% | -2.1% | -227.2% | -1394.6% | -276483.3% | -16929.9% | — | -4845.8% |
| Net margin | -2064.4% | -394.9% | -2482.8% | 1.3% | -230.7% | -1416.0% | -276060.0% | -17094.2% | — | -4977.3% |
| FCF margin | -1543.0% | -242.1% | -1025.7% | -36.3% | -166.9% | -1246.8% | -264293.3% | -14895.4% | — | -4367.7% |
| Return on assets | -136.7% | -95.5% | -64.2% | 0.9% | -94.2% | -114.9% | -187.7% | -145.6% | — | -30.5% |
| Return on equity | 88.4% | 204.2% | -310.6% | 1.0% | -207.8% | -275.8% | -350.6% | -275.4% | — | -36.1% |
| Debt / equity | — | — | — | — | — | 0.45× | 0.42× | 0.37× | 0.12× | 0.11× |
| Current ratio | 4.44 | 4.42 | 8.54 | 9.08 | 1.82 | 2.31 | 4.10 | 2.90 | 11.20 | 15.59 |
Source: SEC EDGAR filings · CIK 0001539029 · US · as of 2024-12-31. facts plus Stocktoria's own computed scores — not investment advice.